Treatment with mycophenolate and cyclophosphamide leads to clinically meaningful improvements in patient-reported outcomes in scleroderma lung disease: results of Scleroderma Lung Study II - Volkmann, E R; Tashkin, D P; LeClair, H (ACR Open Rheumatol, 2020)